Results 131 to 140 of about 15,547 (188)

Stage-associated immunoproteomic profiling of serum autoantibody-captured retinal antigens in age-related macular degeneration. [PDF]

Front Immunol
Lin H, Wolfrum P, Kempf LF, Wolters D, Perumal N, Korb CA, Grus FH.   +6 more
europepmc   +1 more source

Faricimab in the Treatment of Retinal Disease: A Narrative Review. [PDF]

Cureus
Zeaiter M, Jaber H, Gharbi K, Fernandes SMB, Mchaik J, Ahmed M, Hassan A, Hammoud AA.   +7 more
europepmc   +1 more source

Enhanced Macular Imaging Referral Pathway: Bridging Community Optometrists and Hospital Specialists for Smarter Eye Care. [PDF]

Ophthalmol Ther
Salvatore S, Harvey J, Hughes A, Gibson L, Hopcroft J, Swift S, Marsterson J, Bailey C.   +7 more
europepmc   +1 more source

Real-World Outcomes of Faricimab in Patients with Highly Refractory Neovascular Age-Related Macular Degeneration in Portugal: The REVEAL Study. [PDF]

Ophthalmol Ther
Mira F, Donato S, Vaz F, Madeira F, Picoto M, Mendes A, Beato J, Torres-Costa S, Pinto C, Oliveira N, Feliciano S, Lume M, Carreiro R, Couto M, Carneiro Â.   +14 more
europepmc   +1 more source

Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval. [PDF]

Clin Ophthalmol
Şatırtav G, Lövestam-Adrian MK, Chang W, Charles M, Chen LJ, Cheung CMG, Kodjikian L, Ohji M, Zinkernagel M, Wolf S.   +9 more
europepmc   +1 more source

Optimising the patient pathway for macular conditions requiring intravitreal injections. [PDF]

BMJ Open Ophthalmol
Wilkinson E, Beresford S, Mushtaq B, Salvatore S, Sivaprasad S, Brown K, Carter JS, Singh J, Schrire T, Chase TJG.   +9 more
europepmc   +1 more source

Clinical Value of Optical Coherence Tomography Angiography in Neovascular Age-Related Macular Degeneration. [PDF]

J Clin Med
Asanad S, Thomspon J.
europepmc   +1 more source

Faricimab for treatment-naïve nAMD: 1- and 2-year outcomes and PS-OCT polarimetric entropy. [PDF]

Int Ophthalmol
Katabami T, Ota M, Saeki Y, Yashiro K, Aoki S, Kitamoto K, Terao R, Azuma K.   +7 more
europepmc   +1 more source

Effects of vascular endothelial growth factor and angiopoietin-2 inhibitions on intraretinal hyperreflective foci in neovascular age-related macular degeneration. [PDF]

Jpn J Ophthalmol
Nakanishi Y, Akada M, Tamiya R, Ideyama M, Kogo T, Ichioka A, Yamamoto A, Ueda-Arakawa N, Tamura H, Miyata M, Takahashi A, Kido A, Muraoka Y, Miyake M, Ooto S, Tsujikawa A, Hata M.   +16 more
europepmc   +1 more source

Author Correction: Sustainability in medical retina: the environmental impact of using aflibercept 8 mg instead of aflibercept 2 mg in treatment-naïve patients with nAMD. [PDF]

Eye (Lond)
Bowley N, Thomas P, Sivaprasad S, Purbrick RMJ, Beardmore E, Gilbert R, Clarke A, Chase TJG.   +7 more
europepmc   +1 more source